Source: http://www.praktikosinstitute.org/health-research/prostate-enlargement-alternative-treatments/
Timestamp: 2019-04-19 18:57:05+00:00

Document:
Weisser, H., B. Behnke, B. Helpap, D. Bach, and M. Krieg. “Enzyme Activities in Tissue of Human Benign Prostatic Hyperplasia after Three Months’ Treatment with the Sabal Serrulata Extract Ids 89 (Strogen) or Placebo.” [In eng]. Eur Urol 31, no. 1 (1997): 97-101.
Melo, E. A., E. B. Bertero, L. A. Rios, and D. Mattos, Jr. “Evaluating the Efficiency of a Combination of Pygeum Africanum and Stinging Nettle (Urtica Dioica) Extracts in Treating Benign Prostatic Hyperplasia (Bph): Double-Blind, Randomized, Placebo Controlled Trial.” [In eng]. Int Braz J Urol 28, no. 5 (Sep-Oct 2002): 418-25.
Koch, E. “Extracts from Fruits of Saw Palmetto (Sabal Serrulata) and Roots of Stinging Nettle (Urtica Dioica): Viable Alternatives in the Medical Treatment of Benign Prostatic Hyperplasia and Associated Lower Urinary Tracts Symptoms.” [In eng]. Planta Med 67, no. 6 (Aug 2001): 489-500.
Dvorkin, L., and K. Y. Song. “Herbs for Benign Prostatic Hyperplasia.” [In eng]. Ann Pharmacother 36, no. 9 (Sep 2002): 1443-52.
Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasia.
Vacherot, F., M. Azzouz, S. Gil-Diez-De-Medina, M. Colombel, A. De La Taille, M. A. Lefrere Belda, C. C. Abbou, J. P. Raynaud, and D. K. Chopin. “Induction of Apoptosis and Inhibition of Cell Proliferation by the Lipido-Sterolic Extract of Serenoa Repens (Lsesr, Permixon in Benign Prostatic Hyperplasia.” [In eng]. Prostate 45, no. 3 (Nov 1 2000): 259-66.
Pytel, Y. A., A. Vinarov, N. Lopatkin, A. Sivkov, L. Gorilovsky, and J. P. Raynaud. “Long-Term Clinical and Biologic Effects of the Lipidosterolic Extract of Serenoa Repens in Patients with Symptomatic Benign Prostatic Hyperplasia.” [In eng]. Adv Ther 19, no. 6 (Nov-Dec 2002): 297-306.
Evans, J. D., K. Pace, and E. W. Evans. “Natural Therapies Used by Adult Men for the Treatment of Erectile Dysfunction, Benign Prostatic Hyperplasia, and for Augmenting Exercise Performance.” [In eng]. J Pharm Pract 24, no. 3 (Jun 2011): 323-31.
Simon, H. B. “On Call. Last Week I Received a Mailing from a Canadian Company That Did Not Support American Drugs Like Hytrin and Proscar in Dealing with Enlarged Prostates. There Were About 30 Testimonials in Favor of Its Product. The Company Says That Zinc Is an Essential Ingredient to Shrink the Prostate. It Further States the Need for Pyridoxine and Certain Amino Acids, Serenoa, Repens (Saw Palmetto), Serrulata, Panax Extract, and Hydrangea Extract. Comments from Various European Magazines Are Also Cited.” [In eng]. Harv Mens Health Watch 4, no. 9 (Apr 2000): 8.
Maggi, M., C. Crescioli, A. Morelli, E. Colli, and L. Adorini. “Pre-Clinical Evidence and Clinical Translation of Benign Prostatic Hyperplasia Treatment by the Vitamin D Receptor Agonist Bxl-628 (Elocalcitol).” [In eng]. J Endocrinol Invest 29, no. 7 (Jul-Aug 2006): 665-74.
Preuss, H. G., C. Marcusen, J. Regan, I. W. Klimberg, T. A. Welebir, and W. A. Jones. “Randomized Trial of a Combination of Natural Products (Cernitin, Saw Palmetto, B-Sitosterol, Vitamin E) on Symptoms of Benign Prostatic Hyperplasia (Bph).” [In eng]. Int Urol Nephrol 33, no. 2 (2001): 217-25.
Jonas, U., H. Melchior, and H. Rubben. “[Recommendations for Billing Alternative Therapy of Benign Prostatic Hyperplasia. Laser Therapy of Benign Prostatic Hyperplasia].” [In ger]. Urologe A 37, no. 1 (Jan 1998): 110-1.
Lee, J. Y., H. E. Foster, Jr., K. T. McVary, S. Meleth, K. Stavris, J. Downey, and J. W. Kusek. “Recruitment of Participants to a Clinical Trial of Botanical Therapy for Benign Prostatic Hyperplasia.” [In eng]. J Altern Complement Med 17, no. 5 (May 2011): 469-72.
Review: Pygeum africanum extracts improve symptoms and urodynamics in symptomatic benign prostatic hyperplasia.
Barry, M. “Review: Pygeum Africanum Extracts Improve Symptoms and Urodynamics in Symptomatic Benign Prostatic Hyperplasia.” [In eng]. ACP J Club 137, no. 2 (Sep-Oct 2002): 61.
Kondas, J., V. Philipp, and G. Dioszeghy. “Sabal Serrulata Extract (Strogen Forte) in the Treatment of Symptomatic Benign Prostatic Hyperplasia.” [In eng]. Int Urol Nephrol 28, no. 6 (1996): 767-72.
Marks, L. S., and V. E. Tyler. “Saw Palmetto Extract: Newest (and Oldest) Treatment Alternative for Men with Symptomatic Benign Prostatic Hyperplasia.” [In eng]. Urology 53, no. 3 (Mar 1999): 457-61.
Saw palmetto extracts for benign prostatic hyperplasia.
Segars, L. W. “Saw Palmetto Extracts for Benign Prostatic Hyperplasia.” [In eng]. J Fam Pract 48, no. 2 (Feb 1999): 88-9.
Wilt, T. J., A. Ishani, G. Stark, R. MacDonald, J. Lau, and C. Mulrow. “Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia: A Systematic Review.” [In eng]. JAMA 280, no. 18 (Nov 11 1998): 1604-9.
Bauer, H. W., C. Casarosa, M. Cosci, M. Fratta, and G. Blessmann. “[Saw Palmetto Fruit Extract for Treatment of Benign Prostatic Hyperplasia. Results of a Placebo-Controlled Double-Blind Study].” [In ger]. MMW Fortschr Med 141, no. 25 (Jun 24 1999): 62.
Geavlete, P., R. Multescu, and B. Geavlete. “Serenoa Repens Extract in the Treatment of Benign Prostatic Hyperplasia.” [In eng]. Ther Adv Urol 3, no. 4 (Aug 2011): 193-8.
Hamasaki, T., H. Inatomi, T. Katoh, T. Ikuyama, and T. Matsumoto. “Significance of Vitamin D Receptor Gene Polymorphism for Risk and Disease Severity of Prostate Cancer and Benign Prostatic Hyperplasia in Japanese.” [In eng]. Urol Int 68, no. 4 (2002): 226-31.
Steenkamp, V., M. C. Gouws, M. Gulumian, E. E. Elgorashi, and J. van Staden. “Studies on Antibacterial, Anti-Inflammatory and Antioxidant Activity of Herbal Remedies Used in the Treatment of Benign Prostatic Hyperplasia and Prostatitis.” [In eng]. J Ethnopharmacol 103, no. 1 (Jan 3 2006): 71-5.
Buck, A. C., R. Cox, R. W. Rees, L. Ebeling, and A. John. “Treatment of Outflow Tract Obstruction Due to Benign Prostatic Hyperplasia with the Pollen Extract, Cernilton. A Double-Blind, Placebo-Controlled Study.” [In eng]. Br J Urol 66, no. 4 (Oct 1990): 398-404.
Penna, G., B. Fibbi, S. Amuchastegui, E. Corsiero, G. Laverny, E. Silvestrini, A. Chavalmane, et al. “The Vitamin D Receptor Agonist Elocalcitol Inhibits Il-8-Dependent Benign Prostatic Hyperplasia Stromal Cell Proliferation and Inflammatory Response by Targeting the Rhoa/Rho Kinase and Nf-Kappab Pathways.” [In eng]. Prostate 69, no. 5 (Apr 1 2009): 480-93.
Schmidt, K. “[Effect of Radix Urticae Extract and Its Several Secondary Extracts on Blood Shbg in Benign Prostate Hyperplasia].” [In ger]. Fortschr Med 101, no. 15 (Apr 21 1983): 713-6.
The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study.
Relationship between vitamin D receptor gene Fok I polymorphisms and benign prostatic hyperplasia complicated by histological prostatitis .
Ruan, L., W. D. Zhong, Z. M. Li, and X. Hua. “[Relationship between Vitamin D Receptor Gene Fok I Polymorphisms and Benign Prostatic Hyperplasia Complicated by Histological Prostatitis].” [In chi]. Zhonghua Nan Ke Xue 17, no. 10 (Oct 2011): 880-3.
Champault, G., J. C. Patel, and A. M. Bonnard. “A Double-Blind Trial of an Extract of the Plant Serenoa Repens in Benign Prostatic Hyperplasia.” [In eng]. Br J Clin Pharmacol 18, no. 3 (Sep 1984): 461-2.
Hanus, M., and M. Matouskova. “[Alternative Therapy of Benign Prostatic Hyperplasia–the Porges Urospiral].” [In cze]. Rozhl Chir 72, no. 2 (Feb 1993): 70-4.
Hanus, M., and M. Matouskova. “[Antiestrogens (Tamoxifen) in the Alternative Therapy of Benign Prostatic Hyperplasia].” [In cze]. Rozhl Chir 72, no. 7 (Oct 1993): 316-8.
Quiles, M. T., M. A. Arbos, A. Fraga, I. M. de Torres, J. Reventos, and J. Morote. “Antiproliferative and Apoptotic Effects of the Herbal Agent Pygeum Africanum on Cultured Prostate Stromal Cells from Patients with Benign Prostatic Hyperplasia (Bph).” [In eng]. Prostate 70, no. 10 (Jul 1 2010): 1044-53.
Association of genetic variants of the vitamin D receptor (VDR) gene (Fok-I, Taq-I and Bsm-I) with susceptibility of benign prostatic hyperplasia in a North Indian population.
Manchanda, P. K., R. Konwar, V. L. Nayak, V. Singh, and H. K. Bid. “Association of Genetic Variants of the Vitamin D Receptor (Vdr) Gene (Fok-I, Taq-I and Bsm-I) with Susceptibility of Benign Prostatic Hyperplasia in a North Indian Population.” [In eng]. Asian Pac J Cancer Prev 11, no. 4 (2010): 1005-8.
Schatzl, G., A. Gsur, G. Bernhofer, G. Haidinger, S. Hinteregger, C. Vutuc, A. Haitel, et al. “Association of Vitamin D Receptor and 17 Hydroxylase Gene Polymorphisms with Benign Prostatic Hyperplasia and Benign Prostatic Enlargement.” [In eng]. Urology 57, no. 3 (Mar 2001): 567-72.
Habuchi, T., T. Suzuki, R. Sasaki, L. Wang, K. Sato, S. Satoh, T. Akao, et al. “Association of Vitamin D Receptor Gene Polymorphism with Prostate Cancer and Benign Prostatic Hyperplasia in a Japanese Population.” [In eng]. Cancer Res 60, no. 2 (Jan 15 2000): 305-8.
Colli, E., P. Rigatti, F. Montorsi, W. Artibani, S. Petta, N. Mondaini, R. Scarpa, et al. “Bxl628, a Novel Vitamin D3 Analog Arrests Prostate Growth in Patients with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.” [In eng]. Eur Urol 49, no. 1 (Jan 2006): 82-6.
Vahlensieck, W., Jr., A. Volp, W. Lubos, and M. Kuntze. “[Benign Prostatic Hyperplasia–Treatment with Sabal Fruit Extract. A Treatment Study of 1,334 Patients].” [In ger]. Fortschr Med 111, no. 18 (Jun 30 1993): 323-6.
Jonas, A., G. Rosenblat, D. Krapf, W. Bitterman, and I. Neeman. “Cactus Flower Extracts May Prove Beneficial in Benign Prostatic Hyperplasia Due to Inhibition of 5alpha Reductase Activity, Aromatase Activity and Lipid Peroxidation.” [In eng]. Urol Res 26, no. 4 (1998): 265-70.
Yasumoto, R., H. Kawanishi, T. Tsujino, M. Tsujita, N. Nishisaka, A. Horii, and T. Kishimoto. “Clinical Evaluation of Long-Term Treatment Using Cernitin Pollen Extract in Patients with Benign Prostatic Hyperplasia.” [In eng]. Clin Ther 17, no. 1 (Jan-Feb 1995): 82-7.
Aoki, A., K. Naito, O. Hashimoto, M. Yamaguchi, Y. Hara, Y. Baba, T. Wada, et al. “[Clinical Evaluation of the Effect of Tamsulosin Hydrochloride and Cernitin Pollen Extract on Urinary Disturbance Associated with Benign Prostatic Hyperplasia in a Multicentered Study].” [In jpn]. Hinyokika Kiyo 48, no. 5 (May 2002): 259-67.
Krzeski, T., M. Kazon, A. Borkowski, A. Witeska, and J. Kuczera. “Combined Extracts of Urtica Dioica and Pygeum Africanum in the Treatment of Benign Prostatic Hyperplasia: Double-Blind Comparison of Two Doses.” [In eng]. Clin Ther 15, no. 6 (Nov-Dec 1993): 1011-20.
Sokeland, J. “Combined Sabal and Urtica Extract Compared with Finasteride in Men with Benign Prostatic Hyperplasia: Analysis of Prostate Volume and Therapeutic Outcome.” [In eng]. BJU Int 86, no. 4 (Sep 2000): 439-42.
Chatelain, C., W. Autet, and F. Brackman. “Comparison of Once and Twice Daily Dosage Forms of Pygeum Africanum Extract in Patients with Benign Prostatic Hyperplasia: A Randomized, Double-Blind Study, with Long-Term Open Label Extension.” [In eng]. Urology 54, no. 3 (Sep 1999): 473-8.
Al-Shukri, S. H., P. Deschaseaux, I. V. Kuzmin, and R. R. Amdiy. “Early Urodynamic Effects of the Lipido-Sterolic Extract of Serenoa Repens (Permixon(R)) in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.” [In Eng]. Prostate Cancer Prostatic Dis 3, no. 3 (Nov 2000): 195-99.
de Souza, P. A., A. Palumbo, Jr., L. M. Alves, V. P. de Souza, L. M. Cabral, P. D. Fernandes, C. M. Takiya, F. S. Menezes, and L. E. Nasciutti. “Effects of a Nanocomposite Containing Orbignya Speciosa Lipophilic Extract on Benign Prostatic Hyperplasia.” [In eng]. J Ethnopharmacol 135, no. 1 (Apr 26 2011): 135-46.
Marks, L. S., A. W. Partin, J. I. Epstein, V. E. Tyler, I. Simon, M. L. Macairan, T. L. Chan, et al. “Effects of a Saw Palmetto Herbal Blend in Men with Symptomatic Benign Prostatic Hyperplasia.” [In eng]. J Urol 163, no. 5 (May 2000): 1451-6.
Zhang, W., X. Wang, Y. Liu, H. Tian, B. Flickinger, M. W. Empie, and S. Z. Sun. “Effects of Dietary Flaxseed Lignan Extract on Symptoms of Benign Prostatic Hyperplasia.” [In eng]. J Med Food 11, no. 2 (Jun 2008): 207-14.
Weisser, H., S. Tunn, B. Behnke, and M. Krieg. “Effects of the Sabal Serrulata Extract Ids 89 and Its Subfractions on 5 Alpha-Reductase Activity in Human Benign Prostatic Hyperplasia.” [In eng]. Prostate 28, no. 5 (May 1996): 300-6.
Breza, J., O. Dzurny, A. Borowka, T. Hanus, R. Petrik, G. Blane, and H. Chadha-Boreham. “Efficacy and Acceptability of Tadenan (Pygeum Africanum Extract) in the Treatment of Benign Prostatic Hyperplasia (Bph): A Multicentre Trial in Central Europe.” [In eng]. Curr Med Res Opin 14, no. 3 (1998): 127-39.
Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
Stepanov, V. N., L. A. Siniakova, B. Sarrazin, and J. P. Raynaud. “Efficacy and Tolerability of the Lipidosterolic Extract of Serenoa Repens (Permixon) in Benign Prostatic Hyperplasia: A Double-Blind Comparison of Two Dosage Regimens.” [In eng]. Adv Ther 16, no. 5 (Sep-Oct 1999): 231-41.
Barlet, A., J. Albrecht, A. Aubert, M. Fischer, F. Grof, H. G. Grothuesmann, J. C. Masson, et al. “[Efficacy of Pygeum Africanum Extract in the Medical Therapy of Urination Disorders Due to Benign Prostatic Hyperplasia: Evaluation of Objective and Subjective Parameters. A Placebo-Controlled Double-Blind Multicenter Study].” [In ger]. Wien Klin Wochenschr 102, no. 22 (Nov 23 1990): 667-73.
Tiwari, A. “Elocalcitol, a Vitamin D3 Analog for the Potential Treatment of Benign Prostatic Hyperplasia, Overactive Bladder and Male Infertility.” [In eng]. IDrugs 12, no. 6 (Jun 2009): 381-93.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.